Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus

Bettina Sallé1, Patricia Brochard, Olivier Bourry

  • 1Commissariat à L'Energie Atomique (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies (iMETI), Fontenay-aux-Roses, France.

Abstract

Insights

Cell-associated simian immunodeficiency virus (SIV) can infect macaques through vaginal exposure, demonstrating a novel sexual transmission route. This finding is crucial for developing new human immunodeficiency virus (HIV) prevention strategies.

Area of Science:

  • Virology
  • Immunology
  • Primatology

Background:

  • The role of infected semen cells in sexual transmission of human immunodeficiency virus (HIV) remains under investigation.
  • This study utilizes a macaque model infected with simian immunodeficiency virus (SIV) to explore this transmission route.

Purpose of the Study:

  • To investigate the contribution of cell-associated SIV in sexual transmission.
  • To elucidate the mechanisms of SIV infection following vaginal exposure to infected cells.

Main Methods:

  • Spleen cells from SIV-infected macaques were prepared and intravaginally inoculated into recipient macaques.
  • Cell-associated SIV was labeled with CFSE to track infection dynamics.
  • Samples from mucosa and lymphoid tissues were analyzed using flow cytometry, immunohistochemistry, and in situ hybridization at 21 and 45 hours post-exposure.

Main Results:

  • Vaginal exposure to cell-associated SIV resulted in systemic and persistent infection in macaques.
  • The median infectious dose (50% of females) was determined to be 6.69 x 10^5 +/- 2.08 x 10^5 viral DNA copies.
  • CFSE-labeled SIV-positive cells were detected in lymphoid tissues within 1-2 days after exposure.

Conclusions:

  • Exposure of vaginal and cervical mucosa to cell-associated SIV establishes a new mechanism for sexual transmission of SIV and potentially HIV.
  • This discovery has significant implications for the development of novel preventive strategies, such as microbicides.